Core Laboratories NV
NYSE:CLB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Core Laboratories NV
NYSE:CLB
|
NL |
|
Cyberark Software Ltd
NASDAQ:CYBR
|
IL |
|
Agrify Corp
NASDAQ:RYM
|
US |
|
A
|
Astra Agro Lestari Tbk PT
XBER:ASX
|
ID |
|
W
|
Waystream Group AB (publ)
STO:WAYS
|
SE |
|
Sigma Solve Ltd
NSE:SIGMA
|
IN |
|
Cyberoo SpA
MIL:CYB
|
IT |
|
S
|
Sherwood Corporation (Thailand) PCL
SET:SWC
|
TH |
|
T
|
Trakcja SA
WSE:TRK
|
PL |
|
S
|
Sinergi Inti Andalan Prima Tbk PT
IDX:INET
|
ID |
|
R
|
Runner Xiamen Corp
SSE:603408
|
CN |
|
U
|
US GoldMining Inc
NASDAQ:USGO
|
CA |
Wall Street
Price Targets
CLB Price Targets Summary
Core Laboratories NV
According to Wall Street analysts, the average 1-year price target for
CLB
is 16.15 USD
with a low forecast of 11.62 USD and a high forecast of 23.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CLB's stock price target?
Price Target
16.15
USD
According to Wall Street analysts, the average 1-year price target for
CLB
is 16.15 USD
with a low forecast of 11.62 USD and a high forecast of 23.1 USD.
What is Core Laboratories NV's Revenue forecast?
Projected CAGR
-1%
For the last 14 years the
compound annual growth rate for
Core Laboratories NV's revenue is
-4%.
The projected
CAGR
for the next 2 years is
-1%.
What is Core Laboratories NV's Operating Income forecast?
Projected CAGR
6%
For the last 14 years the
compound annual growth rate for
Core Laboratories NV's operating income is
-10%.
The projected
CAGR
for the next 2 years is
6%.
What is Core Laboratories NV's Net Income forecast?
Projected CAGR
12%
For the last 14 years the
compound annual growth rate for
Core Laboratories NV's net income is
-12%.
The projected
CAGR
for the next 2 years is
12%.
